Study Design of a Phase 3, Randomized, Double-Blind Study of Ublituximab Versus Fingolimod in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS II

Drug Category : Array
Conference Category : Array
Lead Author :
Published Date : 05/02/2026
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2026/01/TGTX-ACTRIMS-2026-KIDS-II-Mok.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top